Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Mikashmi Kohli

Biographic Data

ID9066818
NAMEMikashmi Kohli
GIVEN NAMESMikashmi
FAMILY NAMEKohli
SIGNATUREKOHLI M
AFFILIATIONSFIND
ORCID0000-0002-7402-5791
VERIFIEDYes
TOTAL WORKS7
TOTAL CITATIONS0
WORKS AS AUTHOR7
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2022
LATEST PUBLICATION YEAR2025
H-INDEX0
  • Lack of sex- and gender-disaggregated data in diagnostics

    Open Access•Vishwanath Upadhyay, Rishabh Gangwar et al.•ARTICLE•Frontiers in Public Health•2025

    Background: Sex and gender can affect all aspects of health-related behavior, yet there is limited information on how they influence diagnosis of any health condition. This scoping review examined the extent to which sex- and gender-disaggregated data on diagnostics are available for five tracer conditions: tuberculosis, coronavirus disease 2019 (COVID-19), diabetes, malaria, and schistosomiasis. Methods: Publications were searched between 2000 a…

  • WHO target product profile for TB detection at peripheral settings

    Open Access•Mikashmi Kohli, Alexei Korobitsyn et al.•ARTICLE•PLOS Global Public Health•2025

    In 2014, the World Health Organization (WHO) published target product profiles (TPPs) which detailed minimal and optimal criteria to address high-priority TB diagnostic needs. Since then, the TB community’s needs have evolved; there has been a surge in new and innovative platforms suggesting use of alternative non-invasive specimens for TB diagnosis. This updated TPP used evidence-based modelling to guide the decision-making process for specific …

  • Human papillomavirus self-sampling versus provider-sampling in low- and middle-income countries

    Open Access•Jenifer Akoth Otieno, Lisa Were et al.•ARTICLE•Frontiers in Public Health•2024

    Introduction HPV self-sampling is a relatively new, cost-effective and widely accepted method, however, uptake in LMICs remains limited. We aimed to map out the evidence and identify gaps in accuracy, acceptability, cost, equity and uptake of self-sampling vs. provider-sampling in LMICs. Methods We searched: MEDLINE, EMBASE, CINAHL, SCOPUS, Web of Science, and Global Index Medicus, from 1946 to July 2023. Inclusion criteria entailed studies focus…

  • The “ready-to-hand” test

    Open Access•A Street, Eva Vernooij et al.•ARTICLE•PLOS Global Public Health•2023

    This article assesses the availability of essential diagnostic tests in primary health care facilities in two districts in Sierra Leone. In addition to evaluating whether a test is physically present at a facility, it extends the concept of availability to include whether equipment is functional and whether infrastructure, systems, personnel and resources are in place to allow a particular test to be “ready to hand”, that is, available for immedi…

  • Strengthening health systems through essential diagnostic lists and diagnostic network optimization

    Open Access•Kekeletso Kao, Mikashmi Kohli et al.•ARTICLE•PLOS Global Public Health•2023

  • Updating the WHO target product profile for next-generation Mycobacterium tuberculosis drug susceptibility testing at peripheral centres

    Open Access•Emily Lai-Ho MacLean, Paolo Miotto et al.•ARTICLE•PLOS Global Public Health•2023

    There were approximately 10 million tuberculosis (TB) cases in 2020, of which 500,000 were drug-resistant. Only one third of drug-resistant TB cases were diagnosed and enrolled on appropriate treatment, an issue partly driven by a lack of rapid, accurate drug-susceptibility testing (DST) tools deployable in peripheral settings. In 2014, World Health Organization (WHO) published target product profiles (TPPs) which detailed minimal and optimal cri…

  • Most common reasons for primary care visits in low- and middle-income countries

    Open Access•Jacob Bigio, Emily Lai-Ho MacLean et al.•ARTICLE•PLOS Global Public Health•2022

    With the Covid-19 pandemic and the introduction of the WHO’s Essential Diagnostics List (EDL), increasing global attention is focused on the crucial role of diagnostics in achieving universal health coverage. To create national EDLs and to aid health system planning, it is vital to understand the most common conditions with which people present at primary care health facilities. We undertook a systematic review of the most common reasons for prim…

No prominent works on this page.

  • Most common reasons for primary care visits in low- and middle-income countries

    Open Access•Jacob Bigio, Emily Lai-Ho MacLean et al.•ARTICLE•PLOS Global Public Health•2022

    With the Covid-19 pandemic and the introduction of the WHO’s Essential Diagnostics List (EDL), increasing global attention is focused on the crucial role of diagnostics in achieving universal health coverage. To create national EDLs and to aid health system planning, it is vital to understand the most common conditions with which people present at primary care health facilities. We undertook a systematic review of the most common reasons for prim…

  • The “ready-to-hand” test

    Open Access•A Street, Eva Vernooij et al.•ARTICLE•PLOS Global Public Health•2023

    This article assesses the availability of essential diagnostic tests in primary health care facilities in two districts in Sierra Leone. In addition to evaluating whether a test is physically present at a facility, it extends the concept of availability to include whether equipment is functional and whether infrastructure, systems, personnel and resources are in place to allow a particular test to be “ready to hand”, that is, available for immedi…

  • Strengthening health systems through essential diagnostic lists and diagnostic network optimization

    Open Access•Kekeletso Kao, Mikashmi Kohli et al.•ARTICLE•PLOS Global Public Health•2023

  • Updating the WHO target product profile for next-generation Mycobacterium tuberculosis drug susceptibility testing at peripheral centres

    Open Access•Emily Lai-Ho MacLean, Paolo Miotto et al.•ARTICLE•PLOS Global Public Health•2023

    There were approximately 10 million tuberculosis (TB) cases in 2020, of which 500,000 were drug-resistant. Only one third of drug-resistant TB cases were diagnosed and enrolled on appropriate treatment, an issue partly driven by a lack of rapid, accurate drug-susceptibility testing (DST) tools deployable in peripheral settings. In 2014, World Health Organization (WHO) published target product profiles (TPPs) which detailed minimal and optimal cri…

  • Human papillomavirus self-sampling versus provider-sampling in low- and middle-income countries

    Open Access•Jenifer Akoth Otieno, Lisa Were et al.•ARTICLE•Frontiers in Public Health•2024

    Introduction HPV self-sampling is a relatively new, cost-effective and widely accepted method, however, uptake in LMICs remains limited. We aimed to map out the evidence and identify gaps in accuracy, acceptability, cost, equity and uptake of self-sampling vs. provider-sampling in LMICs. Methods We searched: MEDLINE, EMBASE, CINAHL, SCOPUS, Web of Science, and Global Index Medicus, from 1946 to July 2023. Inclusion criteria entailed studies focus…

  • Lack of sex- and gender-disaggregated data in diagnostics

    Open Access•Vishwanath Upadhyay, Rishabh Gangwar et al.•ARTICLE•Frontiers in Public Health•2025

    Background: Sex and gender can affect all aspects of health-related behavior, yet there is limited information on how they influence diagnosis of any health condition. This scoping review examined the extent to which sex- and gender-disaggregated data on diagnostics are available for five tracer conditions: tuberculosis, coronavirus disease 2019 (COVID-19), diabetes, malaria, and schistosomiasis. Methods: Publications were searched between 2000 a…

  • WHO target product profile for TB detection at peripheral settings

    Open Access•Mikashmi Kohli, Alexei Korobitsyn et al.•ARTICLE•PLOS Global Public Health•2025

    In 2014, the World Health Organization (WHO) published target product profiles (TPPs) which detailed minimal and optimal criteria to address high-priority TB diagnostic needs. Since then, the TB community’s needs have evolved; there has been a surge in new and innovative platforms suggesting use of alternative non-invasive specimens for TB diagnosis. This updated TPP used evidence-based modelling to guide the decision-making process for specific …

Medicine (6 works) · Computer Science (4 works) · Business (3 works) · Environmental health (3 works) · Diagnostic test (2 works) · Economic growth (2 works) · Pathology (2 works) · Pneumonia and Respiratory Infections (2 works) · Tuberculosis (2 works) · Tuberculosis Research and Epidemiology (2 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae